If you need more lookups,
subscriptions start at $34 USD/month.
Daniel Dornbusch Work
2019 -now Board Member and CEO @
2018 -now Board Member @ Arrow Immune, Inc.
2017 -now Corporate Advisor @
2018 -now Advisory Board @ DNARx
2018 -now Advisory Board @
2016 -2019 Founder @ Dornbusch & Company
2014 -2016 Co-Founder and CEO @
2011 -2014 Chief Commercial Officer @
2009 -2011 Director, Sales. Americas @
2006 -2009 Business and Corporate Development @
2004 -2006 Group Vice President @
2003 -2004 Team Lead, Medical Education, Hematology Marketing @
1997 -2001 Associate Director, Business Development @
Daniel Dornbusch Education
Harvard Business School
MBA
2001-2003
Tufts Medical School
MS / MA
1996-1998
Cornell University
BA
1992-1996
HRS
Daniel Dornbusch Skills
Business Development
Strategy
Biotechnology
Start-ups
Strategic Planning
Marketing Strategy
Healthcare
Product Launch
Marketing
Oncology
Pharmaceutical Industry
Product Development
Sales
Venture Capital
Cross-functional Team Leadership
Medical Devices
Mergers & Acquisitions
Business Strategy
Due Diligence
Clinical Development
Drug Development
Lifesciences
Biopharmaceuticals
Clinical Trials
Technology Transfer
Commercialization
Immunology
Infectious Diseases
Cancer
Life Sciences
Business Analysis
Social Media
Cross Functional Team Leadership
Microsoft Excel
Mergers and Acquisitions
Research
Start Ups
Management
Daniel Dornbusch Summary
Daniel Dornbusch, is currently a Board Member and CEO at Excision BioTherapeutics. Daniel Dornbusch brings experience from previous roles at Arrow Immune, Inc., Quantum Leap Healthcare Collaborative, DNARx and Clara Health. Daniel Dornbusch holds a 2001 - 2003 MBA @ Harvard Business School. With a robust skill set that includes Business Development, Strategy, Biotechnology, Start-ups, Strategic Planning and more. Daniel Dornbusch has 1 emails on RocketReach.
Looking for a different Daniel Dornbusch?
Find contact details for 700 million professionals.